Вылечить или помочь выздороветь? (обзор литературы)

1. Stamatiou K., Trinchieri M., Perletti G., et al. Chronic prostatitis and related psychological problems. Which came first: the chicken or the egg? A systematic review. Arch Ital Urol Androl. 2023;95(1):11300. https://dx.doi.org/10.4081/aiua.2023.11300

2. Collins M.M., Stafford R.S., O’Leary M.P., Barry M.J. Distinguishing chronic prostatitis and benign prostatic hyperplasia symptoms: results of a national survey of physician visits. Urology. 1999;53(5):921-5. https://dx.doi.org/10.1016/s0090-4295(98)00636-0

3. Andersson J.A., Peniche A.G., Galindo C.L., et al. New host-directed therapeutics for the treatment of Clostridioides difficile infection. mBio. 2020;11(2):e00053-20. https://dx.doi.org/10.1128/mBio.00053-20

4. Ananthakrishnan A.N. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8(1):17-26. https://dx.doi.org/10.1038/nrgastro.2010.190

5. Donskey C.J. Clostridium difficile in Older Adults. Infect Dis Clin North Am. 2017;31(4):743-756. https://dx.doi.org/10.1016/j.idc.2017.07.003.

6. Nasiri M.J., Goudarzi M., Hajikhani B., et al. Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis. Anaerobe. 2018;50:32-37. https://dx.doi.org/10.1016/j.anaerobe.2018.01.011

7. Maroo S., Lamont J.T. Recurrent clostridium difficile. Gastroenterology. 2006;130(4):1311-6. https://dx.doi.org/10.1053/j.gastro.2006.02.044

8. McDonald L.C., Gerding D.N., Johnson S., et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987-994. https://dx.doi.org/10.1093/cid/ciy149

9. Leffler D.A., Lamont J.T. Treatment of Clostridium difficile-associated disease. Gastroenterology. 2009;136(6):1899-912. https://dx.doi.org/10.1053/j.gastro.2008.12.070

10. Peng Z., Jin D., Kim H.B., rt al. Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing. J Clin Microbiol. 2017;55(7):1998-2008. https://dx.doi.org/10.1128/JCM.02250-16

11. Кульчавеня Е.В., Рафальский В.В. Спектр патогенов и их резистентность к антибактериальным препаратам при цистите, пиелонефрите и простатите. Урология. 2025;6:22–26.

12. Палагин И.С., Сухорукова М.В., Дехнич А.В. и др. Состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевыводящих путей в России, Беларуси и Казахстане: результаты многоцентрового международного исследования «Дармис-2018». Урология.2020;1:19-31.

13. Anderson R.U., Orenberg E.K., Morey A., et al. Stress induced hypothalamus-pituitary-adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2009;182(5):2319-24. https://dx.doi.org/10.1016/j.juro.2009.07.042

14. Leukes V., Walzl G., du Plessis N. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis. Front Immunol. 2020;11:451. https://dx.doi.org/10.3389/fimmu.2020.00451

15. Wang J., Chen Q., Shan Q., et al. Clinical development of immuno-oncology therapeutics. Cancer Lett. 2025 May 1;617:217616. https://dx.doi.org/10.1016/j.canlet.2025.217616

16. Tomioka H. Usefulness of Chinese Herbal Medicines as Host-Directed Therapeutics against Mycobacterial Infections: A Review. Am J Chin Med. 2017;45(8):1597-1611. https://dx.doi.org/10.1142/S0192415X17500860

17. Rudick C.N., Berry R.E., Johnson J.R., et al. Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun. 2011 Feb;79(2):628-35. https://dx.doi.org/10.1128/IAI.00910-10

18. Davis S.N., Maykut C.A., Binik Y.M., et al. Tenderness as measured by pressure pain thresholds extends beyond the pelvis in chronic pelvic pain syndrome in men. J Sex Med. 2011 Jan;8(1):232-9. https://dx.doi.org/10.1111/j.1743-6109.2010.02041.x

19. Potts J.M., Pasqualotto F.F. Seminal oxidative stress in patients with chronic prostatitis. Andrologia. 2003 Oct;35(5):304-8.

20. Корнеев И.А. Мужское бесплодие при оксидативном стрессе: пути решения проблемы. Урология. 2022;1:102–108. Korneev I.A. Male infertility in oxidative stress: ways to solve the problem. Urology. 2022;1:102–108. (In Russ.)]. https: //dx.doi.org/10.18565/urology.2022.1.102-108

21. Aubin S., Berger R.E., Heiman J.R., Ciol M.A. The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III. J Sex Med. 2008 Mar;5(3):657-67. https://dx.doi.org/10.1111/j.1743-6109.2007.00736.x

22. McNaughton Collins M., Pontari M.A., O’Leary M.P., et al.; Chronic Prostatitis Collaborative Research Network. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001 Oct;16(10):656-62. https://dx.doi.org/10.1111/j.1525-1497.2001.01223.x

23. Wenninger .K, Heiman J.R., Rothman I., et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996 Mar;155(3):965-8.

24. Mehik A., Hellström P., Sarpola A., Let al. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int. 2001 Jul;88(1):35-8. https://dx.doi.org/10.1046/j.1464-410x.2001.02259.x

25. Борисов В.В. Российская демография, пути улучшения мужского и женского здоровья в аспекте фертильности. Мнение уролога и репродуктолога . Consilium Medicum. 2019;21(7):10–18.

26. Корнеев И.А. Применение антиоксидантной терапии для сохранения и восстановления репродуктивного здоровья мужчин. Клинический разбор в общей медицине. 2025;6(6):101–106.

27. Кульчавеня Е.В. Оксидативный стресс как ключевое звено патогенеза триады заболеваний предстательной железы. Клинический разбор в общей медицине. 2026;7(5):94–99.

28. Ihsan A.U., Khan F.U., Khongorzul P., et al. Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomed Pharmacother. 2018 Oct;106:714-723. https://dx.doi.org/10.1016/j.biopha.2018.06.139

29. Кульчавеня Е.В., Осадчий А.В. Эффективность сперматопротективной терапии на основе Селцинка плюс у больных туберкулезом предстательной железы. Consilium Medicum. 2016;18(7):22–26.

30. Agarwal A., Parekh N., Panner Selvam M.K., et al. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility. World J Mens Health. 2019;37(3):296–312.

31. Esteves S.C. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study. Int Braz J Urol. 2002;28(5):484–485.

32. Maneesh M., Dutta S., Chakrabarti A., Vasudevan D.M. Alcohol abuse-duration dependent decrease in plasma testosterone and antioxidants in males. Indian J Physiol Pharmacol. 2006;50:291–296.

33. Harlev A., Agarwal A., Gunes S.O., et al. Smoking and Male Infertility: An Evidence-Based Review. World J Mens Health. 2015;33(3):143–160. Doi: 10.5534/wjmh.2015.33.3.143

34. Martins A.D., Agarwal A. Oxidation reduction potential: a new biomarker of male infertility. Panminerva Med. 2019;61(2):108–117. Doi: 10.23736/S0031-0808.18.03529-2

35. Leisegang K., Dutta S. Do lifestyle practices impede male fertility? Andrologia. 2021;53(1):e13595. Doi: 10.1111/and.13595

36. Dawson E.B., Harris W.A., Teter M.C., Powell L.C. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril. 1992;58(5):1034–1039.

37. Close C.E., Roberts P.L., Berger R.E. Cigarettes, alcohol and marijuana are related to pyospermia in infertile men. J Urol. 1990;144(4):900–903. Doi: 10.1016/s0022-5347(17)39618-0

38. Maret W. The Arcana of Zinc. J Nutr. 2025 Mar;155(3):669-675. https://dx.doi.org/10.1016/j.tjnut.2025.01.004

39. Dama M.S., Bhat M.N. Mobile phones affect multiple sperm quality traits: a meta-analysis. F1000Res. 2013;12(2):40. Doi: 10.12688/f1000research.2-40.v1

40. Agarwal A., Deepinder F., Sharma R.K., et al. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil Steril. 2008;89(1):124–128. Doi: 10.1016/j.fertnstert.2007.01.166

41. Avendaño C., Mata A., Sanchez Sarmiento C.A., Doncel G.F. Use of laptop computers connected to internet through Wi-Fi decreases human sperm motility and increases sperm DNA fragmentation. Fertil. Steril. 2012;97(1):39–45.e2. Doi: 10.1016/j.fertnstert.2011.10.012

42. Walczak-Jedrzejowska R., Wolski J.K., Slowikowska-Hilczer J. The role of oxidative stress and antioxidants in male fertility. Cent. European. J Urol. 2013;66(1):60-67. Doi: 10.5173/ceju.2013.01.art19

43. Smits R.M., Mackenzie-Proctor R., Yazdani A., et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2019;14;3(3):CD007411. Doi: 10.1002/14651858.CD007411.pub4

44. UNAIDS

45. HIV statistics, globally and by WHO region, 2025. Available from: https://cdn.who.int/media/docs/default-source/hq-hiv-hepatitis-and-stis-library/who-ias-hiv-statistics_2025-new.pdf

46. Hummelen R., Hemsworth J., Reid G. Micronutrients, N-acetyl cysteine, probiotics and prebiotics: a review of effectiveness in reducing HIV progression. Nutrients. 2010;2(6):626–51.

47. Shivakoti R., Gupte N., Yang W-T., et al. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients. 2014;6(11):5061–78.

48. Pourmoradian S., Rezazadeh L., Tutunchi H., Ostadrahimi A. Selenium and zinc supplementation in HIV-infected patients. Int J Vitam Nutr Res. 2024 Apr;94(2):153-159. https://dx.doi.org/10.1024/0300-9831/a000778

49. Baum M., Miguez-Burbano M., Campa A., Shor-Posner G. Selenium and interleukins in persons infected with human immunodeficiency virus type 1. J Infect Dis. 2000;182(Suppl 1):S69–S73.

50. Kupka R., Mugusi F., Aboud S., et al. Randomized, double-blind, placebocontrolled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am J Clin Nutr. 2008;87(6):1802–8.

51. Wang N., Tan H.Y., Li S., et al. Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant. Oxid Med Cell Longev. 2017;2017:7478523. https://dx.doi.org/10.1155/2017/7478523

52. Hasani M., Djalalinia S., Khazdooz M, et al. Effect of selenium supplementation on antioxidant markers: a systematic review and meta-analysis of randomized controlled trials. Hormones (Athens). 2019 Dec;18(4):451-462. https://dx.doi.org/10.1007/s42000-019-00143-3

53. Handa E, Puspitasari I.M., Abdulah R., et al. Recent advances in clinical studies of selenium supplementation in radiotherapy. J Trace Elem Med Biol. 2020 Dec;62:126653. https://dx.doi.org/10.1016/j.jtemb.2020.126653

54. Bray F., Soerjomataram I. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control. In: Gelband H., Jha P,. Sankaranarayanan R., Horton S., editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 2.

55. Kimura T., Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018 Jun;25(6):524-531. https://dx.doi.org/10.1111/iju.13593

56. Fabiani R., Minelli L., Bertarelli G., Bacci S. A Western Dietary Pattern Increases Prostate Cancer Risk: A Systematic Review and Meta-Analysis. Nutrients. 2016 Oct 12;8(10):626. https://dx.doi.org/10.3390/nu8100626

57. Clark L.C., Combs G.F. Jr, Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996 Dec 25;276(24):1957-63.

58. Karunasinghe N., Ng L., Wang A., et alR. Selenium Supplementation and Prostate Health in a New Zealand Cohort. Nutrients. 2019 Dec 18;12(1):2. https://dx.doi.org/10.3390/nu12010002.

59. Gianduzzo T.R., Holmes E.G., Tinggi U., Shahin M., Mactaggart P., Nicol D.. Prostatic and peripheral blood selenium levels after oral supplementation. J Urol. 2003 Sep;170(3):870-3. https://dx.doi.org/10.1097/01.ju.0000081052.51707.cf

60. Karunasinghe N., Han D.Y., Zhu S., et al. Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr Cancer. 2013;65(3):355-66. https://dx.doi.org/10.1080/01635581.2013.760743

61. Zhang W., Joseph E., Hitchcock C., DiSilvestro R.A. Selenium glycinate supplementation increases blood glutathione peroxidase activities and decreases prostate-specific antigen readings in middle-aged US men. Nutr Res. 2011 Feb;31(2):165-8. https://dx.doi.org/10.1016/j.nutres.2010.10.012..

62. Karunasinghe N., Ryan J., Tuckey J., et al. DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):391-7.

63. Karunasinghe N., Han D.Y., Goudie M., et al. Prostate disease risk factors among a New Zealand cohort. J Nutrigenet Nutrigenomics. 2012;5(6):339-51. https://dx.doi.org/10.1159/000346279

64. Joniau S., Goeman L., Roskams T., et al. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia. Urology. 2007 Jun;69(6):1102-6. https://dx.doi.org/10.1016/j.urology.2007.02.063

65. Takata Y., Morris J.S., King I.B., et al. Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue. Prostate. 2009 Nov 1;69(15):1635-42. https://dx.doi.org/10.1002/pros.21012

66. Karunasinghe N., Lange K., Han D., et al. Androgen pathway related gene variants and prostate cancer association in Auckland men. Curr Pharm Pers Med. 2013;11:22–30. https://dx.doi.org/10.2174/1875692111311010005

67. Xu H., Liu C., Gu M., et al. Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP). Oncotarget. 2017 Feb 21;8(8):14039-14049. https://dx.doi.org/10.18632/oncotarget.12538

68. Ferguson L.R., Karunasinghe N., Zhu S., et al. Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand. Curr Pharm Pers. Med. 2012;10:204–216. https://dx.doi.org/10.2174/187569212802509997

69. Gärtner R., Albrich W., Angstwurm M.W. The effect of a selenium supplementation on the outcome of patients with severe systemic inflammation, burn and trauma. Biofactors. 2001;14(1-4):199-204. https://dx.doi.org/10.1002/biof.5520140125

70. Steinbrenner H., Klotz L.O. Selen und Zink: „Antioxidanzien“ für ein gesundes Altern?

71. Rayman M.P. Selenium and human health. Lancet. 2012 Mar 31;379(9822):1256-68. https://dx.doi.org/10.1016/S0140-6736(11)61452-9

72. Эбзеева Е.Ю., Остроумова О.Д., Кроткова И.Ф., Долдо Н.М. Астения: актуальные вопросы диагностики и коррекции. Терапия. 2025;11(6):190-197.

73. Vinceti M., Filippini T., Del Giovane C., et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. https://dx.doi.org/0.1002/14651858.CD005195.pub4

74. Bryan R.T., Pirrie S.J., Abbotts B., et al.; SELENIB Investigators. Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial. JAMA Netw Open. 2023 Oct 2;6(10):e2337494. https://dx.doi.org/10.1001/jamanetworkopen.2023.37494

75. Baddam S., Maxfield L., Shukla S., Crane J.S. Zinc Deficiency. 2025 Aug 2. In: StatPearls

76. Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr. 2013 Jan 1;4(1):82-91. https://dx.doi.org/10.3945/an.112.003038

77. Maret W. Zinc in Cellular Regulation: The Nature and Significance of «Zinc Signals». Int J Mol Sci. 2017 Oct 31;18(11):2285. https://dx.doi.org/10.3390/ijms18112285

78. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev. 1993 Jan;73(1):79-118. https://dx.doi.org/10.1152/physrev.1993.73.1.79

79. Andreini C., Banci L., Bertini I., Rosato A. Counting the zinc-proteins encoded in the human genome. J Proteome Res. 2006 Jan;5(1):196-201. https://dx.doi.org/10.1021/pr050361

80. Kocyła A., Tran J.B., Krężel A. Galvanization of Protein-Protein Interactions in a Dynamic Zinc Interactome. Trends Biochem Sci. 2021 Jan;46(1):64-79. https://dx.doi.org/10.1016/j.tibs.2020.08.011

81. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science. 1996 Feb 23;271(5252):1081-5. https://dx.doi.org/10.1126/science.271.5252.1081

82. Wessels I., Fischer H.J., Rink L. Dietary and Physiological Effects of Zinc on the Immune System. Annu Rev Nutr. 2021 Oct 11;41:133-175. https://dx.doi.org/10.1146/annurev-nutr-122019-120635

83. Schulz M.T., Rink L. Zinc deficiency as possible link between immunosenescence and age-related diseases. Immun Ageing. 2025 May 19;22(1):19. https://dx.doi.org/10.1186/s12979-025-00511-1

84. Frederickson C.J., Koh J.Y., Bush A.I. The neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005 Jun;6(6):449-62. https://dx.doi.org/10.1038/nrn1671

85. Martinez S.S., Campa A., Li Y., Fleetwood C., et al. Low plasma zinc is associated with higher mitochondrial oxidative stress and faster liver fibrosis development in the Miami adult studies in HIV cohort. J Nutr. 2017;147(4):556–62.

86. Shah K.K., Verma R., Oleske J.M., et al. Essential trace elements and progression and management of HIV infection. Nutr Res. 2019;71:21–9.

87. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Radic Biol Med. 2004;37(8):1182–90.

88. Попова В., Кожин А., Афонин А. и др. Комплексная терапия функциональной задержки полового развития у мальчиков-подростков. Врач. 2015;3:50-53.

89. Zečević N., Veselinović A., Perović M., Stojsavljević A. Association Between Zinc Levels and the Impact of Its Deficiency on Idiopathic Male Infertility: An Up-to-Date Review. Antioxidants (Basel). 2025 Jan 29;14(2):165. https://dx.doi.org/10.3390/antiox14020165

90. Попова Е.Н., Митькина М.И., Чинова А.А., Пономарева Л.А. Роль витаминов и микроэлементов в профилактике и лечении бронхолегочных заболеваний у взрослых. Клинический разбор в общей медицине. 2023;4(2):36-42.

91. Boitani C., Puglisi R. Selenium, a key element in spermatogenesis and male fertility. Adv Exp Med Biol. 2008;636:65-73. https://dx.doi.org/10.1007/978-0-387-09597-4_

92. Wu P.Y., Tan X., Wang M., et al. Selenium supplementation for polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Gynecol Endocrinol. 2022 Nov;38(11):928-934. https://dx.doi.org/10.1080/09513590.2022.2118709

93. Zhao J., Dong L., Lin Z., et al. Effects of selenium supplementation on Polycystic Ovarian Syndrome: a systematic review and meta-analysis on randomized clinical trials. BMC Endocr Disord. 2023 Feb 6;23(1):33. https://dx.doi.org/10.1186/s12902-023-01286-6

94. Mintziori G., Mousiolis A., Duntas L.H., Goulis D.G. Evidence for a manifold role of selenium in infertility. Hormones (Athens). 2020 Mar;19(1):55-59. https://dx.doi.org/10.1007/s42000-019-00140-6

95. Трухан Д.И., Багишева Н.В. Витаминно-минеральные комплексы в помощь взрослым пациентам, часто болеющим острыми респираторными вирусными инфекциями. Consilium Medicum. 2024;26(3):164-71.

96. Трухан Д.И., Викторова И.А., Иванова Д.С., Голошубина В.В. Острые респираторные вирусные инфекции: возможности витаминно-минеральных комплексов в лечении, профилактике и реабилитации. Фарматека. 2023;30(1-2):136-45.

97. Трухан Д.И., Иванова Д.С. Витаминно-минеральные комплексы в профилактике, лечении и на этапе реабилитации после острых респираторных вирусных инфекций и новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2022;3(5):33-46.

98. Трухан Д.И., Шуганова П.В., Степанов И.Н. и др. Нутрицевтики в комплексной терапии астенического синдрома после перенесенной острой респираторной вирусной инфекции. Клинический разбор в общей медицине. 2025;6(8):78–85.

99. Попова Е.Н., Пономарева Л.А., Чинова А.А., Андрианов А.И. Комплексный подход к терапии острых респираторных вирусных инфекций. Клинический разбор в общей медицине. 2023;4(8):42-5.

100. Carfì A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324(6):603-5. https://dx.doi.org/10.1001/jama.2020.12603

101. Townsend L., Dowds J., O’Brien K. et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 2021. https://dx.doi.org/10.1513/AnnalsATS.202009-1175OC

102. Ostojic S.M. Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Nutrients 2021;13(2):503. https://dx.doi.org/10.3390/nu13020503

103. Logan A.C., Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 2001;6(5):450-9.

104. Campagnolo N., Johnston S., Collatz A. et al. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. J Hum Nutr Diet 2017;30(3):247-59. https://dx.doi.org/10.1111/jhn.12435

105. Bjørklund G., Dadar M., Pen J.J. et al. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother 2019;(109):1000-7. https://dx.doi.org/10.1016/j.biopha.2018.10.076

106. Maksoud R., Balinas C., Holden S. et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med 2021;19(1):81. https://dx.doi.org/10.1186/s12967-021-02742-4

107. Butters D., Whitehouse M. COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials. Inflammopharmacology 2021;29(1):101-5. https://dx.doi.org/10.1007/s10787-020-00774-8

108. Vollbracht C., Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients 2021;13(4):1154. https://dx.doi.org/10.3390/nu13041154